Attachments
Highlights
1. In December, confirmed malaria cases declined by 74.4% compared with November, decreasing from 4,804 to 1,228.
2. More than an 85% reduction in reported suspected dengue fever cases to 340 from 2,357 recorded in November.
3. Over 170,000 individuals returned to Afghanistan through official PoEs, placing significant pressure on health services, which delivered 40,501 outpatient consultations.
4. Over 224,000 people received outpatient medical consultations through WHO-supported primary health centers and hospitals.
Epidemiological overview
Disease Outbreaks:
Acute Watery Diarrhea (AWD): In December 2025, a total of 7,969 new cases and three associated deaths (CFR: 0.04%) were reported, compared to 9,548 cases and four deaths in November. This represents a 16.5% decrease from the previous month and reflects a continued downward trend since August 2025, following the earlier rise observed in February 2025.
Acute Respiratory Infection (ARI)-Pneumonia: In December, the surveillance system recorded 183,302 cases of ARI pneumonia and 352 deaths (CFR 0.2%) indicating a 24.6% increase compared to the 147,138 cases and 248 deaths reported in November.
Suspected Dengue Fever: A total of 340 suspected dengue cases were reported in December reflecting an 85.6% decrease compared to November where 2,357 suspected cases with three associated deaths were recorded. Confirmed Malaria: During the reporting period, a total of 1,228 confirmed malaria cases were reported compared to 4,804 cases in November, marking a 74.4% decrease from the previous month. No malariaassociated deaths have been reported since the beginning of 2025.
Suspected Measles: A total of 2,095 new measles cases with 10 associated deaths (CFR 0.5%) were reported, reflecting a 1.5% decrease compared to 2,126 cases and 11 deaths reported in November. Comparatively, there isn’t significant change in the case count reported in the months of November and December.
COVID-19: During the reporting period, 131 confirmed COVID-19 cases were reported, with no associated deaths compared to 206 cases and zero death in November. This indicates a 36.4% decrease in number of confirmed cases. In December 2025, public laboratories tested 2,721 samples from suspected cases, with a positivity rate of 4.8%, marking a 30.1% decrease in testing compared to 3,891 samples tested in November.
Suspected Crimean–Congo Hemorrhagic Fever (CCHF): A total of 37 new CCHF cases with one associated death (CFR 2.7%) were reported, reflecting a 21.3% decrease compared to November. There is an observed reduction of CFR which stood at 8.5% for the month of November.